Published in Ther Hung on January 01, 1980
Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients. Atherosclerosis (2001) 1.72
How best to fight that nasty itch - from new insights into the neuroimmunological, neuroendocrine, and neurophysiological bases of pruritus to novel therapeutic approaches. Exp Dermatol (2005) 1.51
Acute postnatal increase of extracellular antioxidant defence of neonates: the role of iron metabolism. Acta Paediatr (2001) 1.39
High prevalence of silent celiac disease in preschool children screened with IgA/IgG antiendomysium antibodies. J Pediatr Gastroenterol Nutr (1999) 1.30
Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity. J Allergy Clin Immunol (2001) 1.29
Chemokine receptor CCR2 and CCR5 polymorphisms in children with insulin-dependent diabetes mellitus. Pediatr Res (1999) 1.12
Lymphocyte surface immunoglobulins in autoimmune diseases. Lancet (1973) 1.11
Resiniferatoxin-type phorboid vanilloids display capsaicin-like selectivity at native vanilloid receptors on rat DRG neurons and at the cloned vanilloid receptor VR1. Br J Pharmacol (1999) 1.02
The effect of single large dose hydrocortisone treatment on IgM and IgG antibody production, morphological distribution of antibody producing cells and immunological memory. Immunology (1971) 0.99
Ligand inhibition studies on the role of Fc receptors in antibody-dependent cell-mediated cytotoxicity. Mol Immunol (1984) 0.93
Specificity of trypsin and alpha-chymotrypsin towards neutral substrates. Acta Biochim Biophys Acad Sci Hung (1976) 0.93
Antibody dependent and spontaneous lymphocyte mediated cytotoxicity in normal subjects, patients with SLE, and malignancies. Acta Med Acad Sci Hung (1977) 0.87
HL-A and systemic lupus erythematosus. Haematologia (Budap) (1973) 0.86
Secretagogue globulins in the blood of duodenal ulcer patients. Acta Med Acad Sci Hung (1973) 0.86
A non-pungent triprenyl phenol of fungal origin, scutigeral, stimulates rat dorsal root ganglion neurons via interaction at vanilloid receptors. Br J Pharmacol (1999) 0.85
Role of a secretagogue immunoglobulin in gastric acid secretion. Acta Physiol Acad Sci Hung (1982) 0.84
A high sensitive method for the measurement of ATPase activity. Anal Biochem (1977) 0.83
Effect of phytohaemagglutinin on plaque forming cells in the mouse spleen. Nature (1969) 0.83
Association between HLA B7, DR2 and dysfunction of natural- and antibody-mediated cytotoxicity without connection with the deficient interferon production in multiple sclerosis. Hum Immunol (1982) 0.83
Troponin C like protein of blood platelets. FEBS Lett (1977) 0.83
Acute phase proteins in patients with chronic periapical granuloma before and after surgical treatment. Oral Microbiol Immunol (1988) 0.83
Development of 'pharmacological denervation phenomenon' in patients treated with atropine. Eur J Pharmacol (1967) 0.82
Letter: Rosette stimulation by plant mitogens. Lancet (1973) 0.81
Circulating immune complexes and phagocytic activity of polymorphonuclear cells in patients with glomerulopathies. Clin Nephrol (1979) 0.81
Evaluation of different methods for detecting circulating immune complexes. Studies in patients with lung cancer. J Immunol Methods (1981) 0.81
Measurement of Na+/K+-ATPase activity with an automated analyzer. Clin Chem (1997) 0.81
[Anthracosis in members of the aristocracy and mummies in Hungary]. Orv Hetil (1997) 0.81
Electrophysiological effects of intrapericardial infusion of endothelin-1. Pacing Clin Electrophysiol (1998) 0.80
Characterisation of cytokine mRNA expression in tumour-infiltrating mononuclear cells and tumour cells freshly isolated from human colorectal carcinomas. Eur Cytokine Netw (2001) 0.80
[Association between cumulative familial incidence of type I diabetes and rheumatoid arthritis]. Orv Hetil (1985) 0.80
Lymphocyte surface immunoglobulins in Hodgkin's disease. N Engl J Med (1973) 0.80
Functional and structural properties of Na+/K(+)-ATPase enzyme in neonatal erythrocytes. Eur J Clin Invest (1998) 0.80
Effect of propranolol on heart rate variability in patients with end-stage renal disease: a double-blind, placebo-controlled, randomized crossover pilot trial. Clin Nephrol (2004) 0.79
Enhanced accumulation of pericardial fluid adenosine and inosine in patients with coronary artery disease. Life Sci (1999) 0.79
Resynthesis of trypsinized sheep red blood cell receptors on human lymphocytes: comparison of the effects of immunopotentiators of biological and synthetic origin in vitro. Immunopharmacology (1981) 0.79
Distinct features of recombinant rat vanilloid receptor-1 expressed in various expression systems. Cell Mol Life Sci (2003) 0.79
Mastomys natalensis as an experimental host for Brugia malaye subperiodic. Southeast Asian J Trop Med Public Health (1975) 0.79
Experimental glomerular lesions induced by chronic immune complex formation. I. Formation and elimination of the immune complex (relationship between the immune status and the glomerular changes). Int Urol Nephrol (1979) 0.79
Effect of histamine receptor blocking on human antibody-dependent cell-mediated cytotoxicity. Scand J Immunol (1981) 0.79
Non-T-cell resistance against a mouse Moloney lymphoma. Int J Cancer (1976) 0.79
The selective endothelin-A-receptor antagonist LU 135.252 inhibits the direct arrhythmogenic action of endothelin-1. J Cardiovasc Pharmacol (2000) 0.79
Arrhythmogenic action of endothelin-1. Cardiovasc Res (2000) 0.79
Induction of anti-F(ab)2 gamma antibodies by buffy coat transfusions and their effect in kidney transplantation. Transplant Proc (1990) 0.78
Studies directed towards efficient synthesis of oligo-5'-deoxy-5-C-(phosphonomethyl)deoxyribonucleosides. Nucleic Acids Symp Ser (1991) 0.78
Remarkably reduced transplant-related complications by dibromomannitol non-myeloablative conditioning before allogeneic bone marrow transplantation in chronic myeloid leukemia. Acta Haematol (2001) 0.78
Convenient synthesis of dinucleotide methylphosphonates. Nucleic Acids Symp Ser (1991) 0.77
Effect of phytohaemagglutinin and concanavalin A on human rosette-forming cells. Experientia (1974) 0.77
Systemic lupus erythematosus caused by hydantoin preparations. Ann Immunol Hung (1972) 0.77
Vitamins and continuous ambulatory peritoneal dialysis (CAPD). Int Urol Nephrol (1985) 0.77
[Gastric and duodenal intramural hematoma: report of two cases]. Orv Hetil (1998) 0.77
Lack of association between atopic eczema/dermatitis syndrome and polymorphisms in the promoter region of RANTES and regulatory region of MCP-1. Allergy (2002) 0.77
Effect of histamine-receptor blocking on human spontaneous lymphocyte-mediated cytotoxicity. Scand J Immunol (1981) 0.77
Bosentan the mixed endothelin-A- and -B-receptor antagonist suppresses intrapericardial endothelin-1-induced ventricular arrhythmias. J Cardiovasc Pharmacol (2000) 0.77
[In vitro study on the absorption capacity of the small intestine following supraletal x-ray irradiation]. Strahlentherapie (1966) 0.76
Genetic polymorphism of the Gypsy population in Hungary as based on studies of red blood cell antigens. Haematologia (Budap) (1985) 0.76
High anti-paternal cytotoxic T-lymphocyte precursor frequencies in women with unexplained recurrent spontaneous abortions. Hum Reprod (2001) 0.76
Effect in vivo and in vitro treatment with dialyzable leukocyte extracts on human natural killer cell activity. Clin Immunol Immunopathol (1982) 0.76
Hyperhomocysteinaemia and MTHFR C677T gene polymorphism in renal transplant recipients. Arch Dis Child (2001) 0.76
Endothelin-A-receptor antagonist LU 135.252 inhibits the formation of ventricular arrhythmias caused by intrapericardial infusion of endothelin-1. J Cardiovasc Pharmacol (2000) 0.76
The effect of thyrotropic hormone treatment on the epiphyseal cartilage of the white rat. Acta Morphol Acad Sci Hung (1969) 0.76
Comparative study of alloimmune reactions induced by leukocyte and platelet transfusions in humans: characteristic changes of activation markers, gamma interferon, and FcR blocking antibody production. Hum Immunol (1988) 0.76
HLA-G gene polymorphism in the normal population and in recurrent spontaneous abortion in Hungary. Transplant Proc (1999) 0.76
Retroperitoneal plasmocytic giant lymph node hyperplasia. J R Soc Med (1984) 0.75
Immunosuppressive therapy of myasthenia gravis. Acta Med Acad Sci Hung (1970) 0.75
[Management of multinodular non-toxic goiter]. Orv Hetil (1994) 0.75
Chemotherapeutic studies on experimental Schistosoma mansoni infection of Mastomys natalensis. Bull World Health Organ (1971) 0.75
Cytotoxic effect of anti-H-2 and anti-Ia antisera on human B and T cells. Scand J Immunol (1977) 0.75
Observations with 5-hydroxyurea in the management of polycythaemia vera. Ther Hung (1972) 0.75
[Myasthenia gravis treated with immunosuppressive drugs]. Orv Hetil (1969) 0.75
Functional changes of the adrenal gland after supralethal total-body irradiation. Radiobiol Radiother (Berl) (1967) 0.75
[The diary of Philip Blaiberg]. Orv Hetil (1970) 0.75
[Therapy of polycythemia rubra vera using Zitostop]. Orv Hetil (1970) 0.75
[Experimental proof on the mechanism of origine of functional atelectasis in bronchial stress]. Z Tuberk Erkr Thoraxorg (1966) 0.75
[Skin transplantation experiments after irradiation with high doses]. Strahlentherapie (1967) 0.75
[Suppressibility of the thyroid function following radioiodine therapy of hyperthyroidism. When is Basedow-Graves disease completely cured?]. Orv Hetil (1972) 0.75
[Diagnostic significance of the rheumatoid rosette test]. Orv Hetil (1973) 0.75
[Immunosuppressive therapy of uveitis with corticosteroids and cytostatic drugs]. Orv Hetil (1972) 0.75
[Immunological status of patients with Basedow-Graves disease treated with radio-iodine]. Orv Hetil (1972) 0.75
[Changes in the adrenal cortical function under the effect of supralethal total body irradiation]. Orv Hetil (1966) 0.75
[Tuberculin sensitivity tests, using leukocyte migration inhibition, in patients with autoimmune diseases undergoing immunosuppressive therapy]. Orv Hetil (1973) 0.75
The effect of phytohaemagglutinin on plaque forming cells in the mouse spleen and on skin graft rejection. Folia Biol (Praha) (1969) 0.75
[Results of radioactive phosphorus treatment of 50 patients with erythremia]. Probl Gematol Pereliv Krovi (1969) 0.75
Potentiation of glibenclamide-induced insulin release by calcium infusion. Diabetologia (1977) 0.75
[The treatment of autoimmune myositis with R-74]. Orv Hetil (1970) 0.75
[Study of human antibody-dependent cellular cytotoxicity (ADCC) in an allogenic system]. Orv Hetil (1977) 0.75
[Our experience with monocomponent insulin therapy]. Orv Hetil (1977) 0.75
[Comparative studies on the protective mechanism of cysteamine and AET in "intestinal irradiation death"]. Strahlentherapie (1965) 0.75
[Diabetic ketoacidosis treated with low doses of intravenous insulin]. Orv Hetil (1977) 0.75
[Treatment of chronic myeloid leukemia with Myelobromol]. Orv Hetil (1967) 0.75
[The use of immunospecific rosette formation inhibition in the comparative study of 2 prednisolone derivatives]. Orv Hetil (1973) 0.75
Protective effect of anti-mouse-skin-epithelium rabbit-IgG on survival of mouse-skin homografts. Acta Med Acad Sci Hung (1973) 0.75
[Experience with the 5-hydroxyurea therapy of polycythemia rubra vera]. Orv Hetil (1972) 0.75
[Recovery from chronic bone marrow aplasia in a young mother after injection of amniotic sac and liver cells from her own 22mm sized fetus. Preliminary report]. Orv Hetil (1973) 0.75
[Diagnosis of the pathogenesis of autoimmunity]. Orv Hetil (1970) 0.75
Steroid treatment of lupus nephropathy: results of 60 cases. Acta Med Acad Sci Hung (1967) 0.75
[Cytotoxic effect of human blood lymphocytes in homologous tissue culture]. Orv Hetil (1972) 0.75
[Characteristics of phytohemagglutinin reactivity of human lymphocytes]. Orv Hetil (1977) 0.75
Treatment of polycythaemia vera with Myelobromol. Ther Hung (1969) 0.75
New cytostatic drugs in the management of polycythaemia vera. Ther Hung (1972) 0.75